{"id":"W3032613529","doi":"10.1200/jco.2020.38.15_suppl.e14133","title":"Reimbursement recommendations for cancer drugs supported by phase II evidence in Canada.","year":2020,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Canadian Agency for Drugs and Technologies in Health; University of Toronto","funders":"","keywords":"Reimbursement; Medicine; Logistic regression; Family medicine; Test (biology); Internal medicine; Health care","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1091288,0.0006158107,0.001209307,0.006947863,0.003237186,0.00707178,0.003361089,0.004843476,0.007098909],"category_scores_gemma":[0.3469615,0.001087657,0.002540805,0.0080655,0.001974354,0.001909059,0.002827117,0.003717342,0.001295857],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.03978882,"about_ca_system_score_gemma":0.2495898,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.6365007,"about_ca_topic_score_gemma":0.7892758,"domain_scores_codex":[0.8899546,0.03041607,0.02638411,0.003658294,0.04511451,0.004472383],"domain_scores_gemma":[0.5079548,0.1416247,0.06976682,0.009219748,0.2412965,0.03013742],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001236154,0.0001611685,0.0509834,0.02095011,0.001243271,0.0007047639,0.001427092,0.001335472,0.0008934064,0.01034014,0.6609425,0.2497825],"study_design_scores_gemma":[0.0008104905,0.0003525743,0.09786103,0.03085544,0.001200111,0.0006668166,0.000877469,0.00195467,0.0008367121,0.002688937,0.8616261,0.0002696319],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.04697098,0.2100437,0.008589054,0.4767683,0.01465184,0.01234344,0.05255137,0.0007259517,0.1773554],"genre_scores_gemma":[0.4955027,0.1289824,0.09515141,0.1951861,0.007368867,0.004619017,0.034602,0.0005819044,0.03800574],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.9602112,"threshold_uncertainty_score":0.7312801,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.7807678611486495,"score_gpt":0.6254082072699962,"score_spread":0.1553596538786532,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}